CUSIP: 05360L205
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
669,617
-
Share change
-
-339,152
-
Total reported value
-
$180,002
-
Price per share
-
$0.27
-
Number of holders
-
15
-
Value change
-
-$129,789
-
Number of buys
-
6
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 05360L205?
CUSIP 05360L205 identifies ATXI - AVENUE THERAPEUTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) as of Q2 2022
As of 30 Jun 2022,
AVENUE THERAPEUTICS INC - COM NEW (ATXI) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
669,617 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, National Asset Management, Inc., HRT FINANCIAL LP, UBS Group AG, BlackRock Inc., TWO SIGMA SECURITIES, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.